no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC)
|
Andrés, R. |
|
2013 |
16 |
3 |
p. 280-284 |
article |
2 |
Changes in the immune cell population and cell proliferation in peripheral blood after gemcitabine-based chemotherapy for pancreatic cancer
|
Homma, Y. |
|
2013 |
16 |
3 |
p. 330-335 |
article |
3 |
Combined preoperative CEA and CD44v6 improves prognostic value in patients with stage I and stage II colorectal cancer
|
Chen, L. |
|
2013 |
16 |
3 |
p. 285-292 |
article |
4 |
Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumours
|
Durán, I. |
|
2013 |
16 |
3 |
p. 322-329 |
article |
5 |
Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
|
García-Carbonero, R. |
|
2013 |
16 |
3 |
p. 243-256 |
article |
6 |
HIV-1 viral protein R downregulates Ebp1 and stabilizes p53 in glioblastoma U87MG cells
|
Zhang, S. |
|
2013 |
16 |
3 |
p. 293-300 |
article |
7 |
MicroRNA-21 in breast cancer: diagnostic and prognostic potential
|
Chen, J. |
|
2013 |
16 |
3 |
p. 225-233 |
article |
8 |
Microvesicle microRNA profiles and functional roles between chronic hepatitis B and hepatocellular carcinoma
|
Li, H. |
|
2013 |
16 |
3 |
p. 315-321 |
article |
9 |
Oropharyngeal cancer related to Human Papilloma Virus: incidence and prognosis in Madrid, Spain
|
Cerezo, L. |
|
2013 |
16 |
3 |
p. 301-306 |
article |
10 |
Overexpressed transcription factor FOXM1 is a potential diagnostic and adverse prognostic factor in postoperational gastric cancer patients
|
Li, X. |
|
2013 |
16 |
3 |
p. 307-314 |
article |
11 |
PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer
|
Vidal, A. C. |
|
2013 |
16 |
3 |
p. 266-272 |
article |
12 |
Recommendations of a group of experts for the pathological assessment of tumour regression of liver metastases of colorectal cancer and damage of non-tumour liver tissue after neoadjuvant therapy
|
Gómez Dorronsoro, M. L. |
|
2013 |
16 |
3 |
p. 234-242 |
article |
13 |
Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in Spain
|
Balañá, C. |
|
2013 |
16 |
3 |
p. 273-279 |
article |
14 |
The clinical significance of memory T cells and its subsets in gastric cancer
|
Zhang, R. |
|
2013 |
16 |
3 |
p. 257-265 |
article |